CytRx Corporation (NASDAQ:CYTR) will probably get a lot of new attention over the next few days and smart traders know the more new people looking at a stock the better the odds of tradeable price swings. This is especially true for over the counter stocks where investor awareness campaigns are the primary market driver. These campaigns generate a buzz and an influx of new interest that can send a stock price soaring.CytRx Corporation (NASDAQ:CYTR) stock in last trading day opened at $4.62, traded the day range of $4.53 – $5.40, and closed at $5.26. The stock showed a positive performance of 13.85% in previous trading session.
Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) announced successful results in a clinical trial testing the pharmacokinetic dose response of its oral insulin capsule (ORMD-0801) in type 1 diabetes patients.Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) traded 7.90 million shares and the average volume of the stock was recorded as 372,271.00 shares. The 52 week range of the stock is $3.72 – $16.38. The stock was advanced 9.99% by closing at $12.99.
Galena Biopharma Inc (NASDAQ:GALE) is developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide.Galena Biopharma Inc (NASDAQ:GALE) stock on December 27, 2013, recorded a rise of 5.41% and was in a range of $4.09 – $4.35 before closing at $4.29. Company’s 52-week low price is $1.48and 52 week high price is $4.78.